Last updated: 17 July 2019 at 8:22am EST

Daniel Couto Net Worth




The estimated Net Worth of Daniel Couto is at least $76.1 Thousand dollars as of 3 November 2015. Daniel Couto owns over 2,867 units of ContraFect Corp stock worth over $666 and over the last 10 years Daniel sold CFRX stock worth over $75,392.

Daniel Couto CFRX stock SEC Form 4 insiders trading

Daniel has made over 6 trades of the ContraFect Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently Daniel sold 2,872 units of CFRX stock worth $10,942 on 17 November 2015.

The largest trade Daniel's ever made was selling 2,872 units of ContraFect Corp stock on 17 November 2015 worth over $10,942. On average, Daniel trades about 1,721 units every 7 days since 2014. As of 3 November 2015 Daniel still owns at least 2,872 units of ContraFect Corp stock.

You can see the complete history of Daniel Couto stock trades at the bottom of the page.



What's Daniel Couto's mailing address?

Daniel's mailing address filed with the SEC is 61 BACON HILL ROAD, , PLEASANTVILLE, NY, 10510.

Insiders trading at ContraFect Corp

Over the last 10 years, insiders at ContraFect Corp have traded over $2,523,392 worth of ContraFect Corp stock and bought 525,578 units worth $426,359 . The most active insiders traders include Sol J Barer, Roger Pomerantz, and Industrial Co., Ltd Fosun. On average, ContraFect Corp executives and independent directors trade stock every 70 days with the average trade being worth of $16,159. The most recent stock trade was executed by Michael Messinger on 13 December 2019, trading 5,000 units of CFRX stock currently worth $1,850.



What does ContraFect Corp do?

we are a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, particularly those treated in hospital-based settings. due to drug-resistant and newly-emerging pathogens, infections in the hospital are already the fourth leading cause of death in the united states, following heart disease, cancer and stroke. we address multi-drug resistant infections using our therapeutic products from our lysin and monoclonal antibody platforms to target the conserved regions of either bacteria or viruses. our strategy is to use our first in class therapies to achieve a leadership position in the treatment of life-threatening infectious diseases, including drug-resistant pathogens. we plan to pursue commercialization of therapeutic products through discovery, acquisition and development of protein and antibody products. our novel lysins are enzymes that are produced in the life cycle stage of bacteriophage, a virus that infects and kills ba



What does ContraFect Corp's logo look like?

ContraFect Corp logo

Complete history of Daniel Couto stock trades at ContraFect Corp

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
17 Nov 2015 Daniel Couto
SVP Manufacturing and Facilities
Sale 2,872 $3.81 $10,942
17 Nov 2015
0
3 Nov 2015 Daniel Couto
SVP Manufacturing and Facilities
Sale 2,867 $4.23 $12,127
3 Nov 2015
2,872
20 Oct 2015 Daniel Couto
SVP Manufacturing and Facilities
Sale 2,867 $4.48 $12,844
20 Oct 2015
5,739
6 Oct 2015 Daniel Couto
SVP Manufacturing and Facilities
Sale 2,867 $4.11 $11,783
6 Oct 2015
8,606
22 Sep 2015 Daniel Couto
SVP Manufacturing and Facilities
Sale 2,867 $4.76 $13,647
22 Sep 2015
10,773
8 Sep 2015 Daniel Couto
SVP Manufacturing and Facilities
Sale 2,867 $4.90 $14,048
8 Sep 2015
14,340


ContraFect Corp executives and stock owners

ContraFect Corp executives and other stock owners filed with the SEC include: